Sunesis Pharmaceuticals Says On Dec 16, Dayton Misfeldt Provided Notice Of Resignation As Co.'s Interim CEO, Effective Dec 31; Board Appointed Parvinder S. Hyare As Interim CEO, Effective Jan 1, 2021